Cargando…

Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

BACKGROUND: Hormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may be transferred from cell-to-cell via microvesicles/exosomes. Here we aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corcoran, Claire, Rani, Sweta, O’Brien, Keith, O’Neill, Amanda, Prencipe, Maria, Sheikh, Rizwan, Webb, Glenn, McDermott, Ray, Watson, William, Crown, John, O’Driscoll, Lorraine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519481/ https://www.ncbi.nlm.nih.gov/pubmed/23251413 http://dx.doi.org/10.1371/journal.pone.0050999

Ejemplares similares

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
por: O'Neill, Amanda J, et al.
Publicado: (2011)

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
por: Corcoran, Claire, et al.
Publicado: (2014)

Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles
por: Martinez, Vanesa G., et al.
Publicado: (2017)

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
por: Eustace, Alex J, et al.
Publicado: (2018)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer
por: Hanrahan, Karen, et al.
Publicado: (2017)

A method of separating extracellular vesicles from blood shows potential clinical translation, and reveals extracellular vesicle cargo gremlin-1 as a diagnostic biomarker
por: McNamee, Niamh, et al.
Publicado: (2021)

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance
por: Breslin, Susan, et al.
Publicado: (2016)

Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4
por: Breslin, Susan, et al.
Publicado: (2017)

Melanoma-associated antigen family protein-D4: clinical significance and functional relevance in breast cancer
por: Germano, S, et al.
Publicado: (2010)

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation
por: Lundon, D. J., et al.
Publicado: (2017)

miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome
por: O’Neill, Sadhbh, et al.
Publicado: (2018)

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
por: Walsh, Naomi, et al.
Publicado: (2009)

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
por: O’Neill, Sadhbh, et al.
Publicado: (2019)

Comparison of three commercial serological tests for the detection of Chlamydia abortus infection in ewes
por: O’Neill, L. M., et al.
Publicado: (2018)

Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
por: O’Driscoll, Lorraine
Publicado: (2020)

PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
por: McDermott, Martina SJ, et al.
Publicado: (2014)

SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue
por: Kennedy, S, et al.
Publicado: (2008)

Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
por: McDermott, Martina S. J., et al.
Publicado: (2023)

Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
por: O’Driscoll, Tristan, et al.
Publicado: (2015)

Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
por: Catalano, Mariadelva, et al.
Publicado: (2019)

Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications
por: Tsiapalis, Dimitrios, et al.
Publicado: (2020)

Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
por: Hu, Jiaru, et al.
Publicado: (2023)

Evidence for the Need to Evaluate More Than One Source of Extracellular Vesicles, Rather Than Single or Pooled Samples Only, When Comparing Extracellular Vesicles Separation Methods
por: Martinez-Pacheco, Sarai, et al.
Publicado: (2021)

Pre-Clinical In Vitro Models Used in Cancer Research: Results of a Worldwide Survey
por: Martinez-Pacheco, Sarai, et al.
Publicado: (2021)

Predictive biomarkers for dasatinib treatment in melanoma
por: Eustace, Alex J., et al.
Publicado: (2014)

Extracellular vesicle separation from milk and infant milk formula using acid precipitation and ultracentrifugation
por: Mukhopadhya, Anindya, et al.
Publicado: (2021)

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
por: McDermott, Martina, et al.
Publicado: (2014)

Role of Epithelial-to-Mesenchymal Transition of Retinal Pigment Epithelial Cells in Glaucoma Cupping
por: O’Driscoll, Eabha, et al.
Publicado: (2023)

The effect of ‘paying for performance’ on the management of type 2 diabetes mellitus: a cross-sectional observational study
por: O'Connor, Raymond, et al.
Publicado: (2020)

Targeting immunometabolism as an anti-inflammatory strategy
por: Pålsson-McDermott, Eva M., et al.
Publicado: (2020)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
por: Omoboyede, Victor, et al.
Publicado: (2023)

Extracellular vesicles report on the MET status of their cells of origin regardless of the method used for their isolation
por: Useckaite, Zivile, et al.
Publicado: (2020)

Exercise Training and Circulating Small Extracellular Vesicles: Appraisal of Methodological Approaches and Current Knowledge
por: Darragh, Ian A. J., et al.
Publicado: (2021)

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells
por: McDermott, Martina S. J., et al.
Publicado: (2019)

Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut
por: O’Connell Motherway, Mary, et al.
Publicado: (2018)

Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
por: Wilson, C, et al.
Publicado: (2008)

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023)

Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide
por: Greene, John, et al.
Publicado: (2019)

Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells
por: Chen, Wei-Xian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gou1oh3og5nlsagbqg4cnop4ka